| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Dipp Michelle serves as a Chief Executive Officer at TPST. Across recent SEC filings that breaks down to 26 buys and 0 sells. Those positions are worth an estimated $6.7M at current prices.
The biggest single holding is TPST (~$6.7M) as Chief Executive Officer. Net of sales, the recent Form 4 record there shows accumulation of 963,656 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2016 | TPST Tempest Therapeutics, Inc. | Chief Executive Officer | Buy | 162,732 | $7.60 | $1,237,092.00 | New | |
| Aug 24, 2015 | TPST Tempest Therapeutics, Inc. | Chief Executive Officer | Buy | 300 | $18.56 | $5,568.00 | - | |
| May 26, 2015 | TPST Tempest Therapeutics, Inc. | Chief Executive Officer | Buy | 300 | $31.02 | $9,306.00 | - | |
| Apr 2, 2015 | TPST Tempest Therapeutics, Inc. | Chief Executive Officer | Buy | 1,000 | $32.49 | $32,490.00 | +0.1% |